Quarterly Transactions Made in Theravance Biopharma, Inc. (TBPH)
This table provides information about the institutional ownership of Theravance Biopharma, Inc. (TBPH). The information is specifically focused on institutions that hold shares of Theravance Biopharma, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 9,920,483 | 14,591,805 | 24,512,288 | 18,331,659 | 5,320,525 | 23,652,184 | 860,104 | |
Q4 2021 | 5,979,078 | 3,613,237 | 9,592,315 | 8,787,703 | 1,853,247 | 10,640,950 | -1,048,635 | |
Q1 2022 | 8,714,364 | 953,903 | 9,668,267 | 4,450,526 | 1,844,099 | 6,294,625 | 3,373,642 | |
Q2 2022 | 6,406,308 | 1,070,537 | 7,476,845 | 4,946,380 | 541,185 | 5,487,565 | 1,989,280 | |
Q3 2022 | 3,467,645 | 4,140,097 | 7,607,742 | 4,711,846 | 34,929 | 4,746,775 | 2,860,967 | |
Q4 2022 | 1,638,783 | 3,238,815 | 4,877,598 | 5,210,244 | 0 | 5,210,244 | -332,646 | |
Q1 2023 | 4,281,956 | 862,652 | 5,144,608 | 5,176,241 | 0 | 5,176,241 | -31,633 | |
Q2 2023 | 1,241,365 | 1,534,744 | 2,776,109 | 9,262,695 | 545,427 | 9,808,122 | -7,032,013 | |
Q3 2023 | 1,439,679 | 2,301,091 | 3,740,770 | 2,785,475 | 545,427 | 3,330,902 | 409,868 | |
Q4 2023 | 1,023,849 | 598,183 | 1,622,032 | 2,746,474 | 80 | 2,746,554 | -1,124,522 | |
Q1 2024 | 1,553,307 | 1,823,102 | 3,376,409 | 3,386,109 | 0 | 3,386,109 | -9,700 | |
Q2 2024 | 4,112,010 | 1,922,359 | 6,034,369 | 5,407,646 | 0 | 5,407,646 | 626,723 | |
Q3 2024 | 4,314,837 | 584,497 | 4,899,334 | 1,116,245 | 0 | 1,116,245 | 3,783,089 |